Our (e)Books and (e)Journals
IOS Press serves the information needs of scientific and medical communities worldwide. See what's new and browse our books and journals to learn more.
Browse by Subject
- Administrative Sciences
- Biochemistry, Medicine & Health
- Computer & Communication Sciences
- Environmental Sciences
- Food & Nutrition
- Geographic Information Science
IOS Press publishes books and journals (online and in print) in a broad range of scientific, technical and medical (STM) subject areas. Click on a subject above to see our titles.
NewsKeep me informed
May 12, 2020 - Amsterdam, NL – Parkinson's disease (PD) is expected to reach over 14 million cases worldwide by 2040. As longevity increases, so does the number of persons living with PD. Writing in the Journal of Parkinson's Disease (JPD), scientists discuss several avenues through which the COVID-19 pandemic might contribute to the expected exponential growth of PD in the coming years, compounding the economic and societal impacts of the disease.May 12, 2020
Passive Immunization May Slow Down SARS-CoV-2 and Boost Immunity in Patients, Buying Time Until Vaccines Are Developed
May 12, 2020 - Amsterdam, NL – The worldwide COVID-19 pandemic has infected more than 4 million people and killed close to 280,000.1 Finding a vaccine has become a global public health priority. However, creating a viable vaccine might take a long time; scientists estimate a vaccine may be available in between 12 and 18 months. A potential interim solution reported in the International Journal of Risk & Safety in Medicine may be a passive vaccine, or passive immummization (PI), which can provide instant, short-term fortification against infectious agents.May 12, 2020
May 6, 2020 - Amsterdam, NL – Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease (PD). In the Journal of Parkinson's Disease scientists report on the possibility of using a multi-arm, multi-stage trial platform to evaluate several potential therapies at once, using lessons learned from other diseases.May 6, 2020
May 5, 2020 - Amsterdam, NL – Two purines, caffeine and urate, have been associated with a reduced risk of Parkinson's disease (PD) in multiple study groups and populations. Analysis of data from the Harvard Biomarkers Study shows that lower levels of caffeine consumption and lower blood urate are inversely associated with PD, strengthening the links between caffeine intake and urate levels and PD, reports a study in the Journal of Parkinson's Disease (JPD).May 5, 2020